tm
Seeing Is Believing
tm
Seeing Is Believing
NMRA is currently covered by 7 analysts with an average price target of $6.67. This is a potential upside of $4.2 (316.88%) from yesterday's end of day stock price of $1.6.
Neumora Therapeutics's activity chart (see below) currently has 43 price targets and 53 ratings on display. The stock rating distribution of NMRA is 61.54% BUY and 38.46% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.89% with an average time for these price targets to be met of 17.73 days.
Highest price target for NMRA is $14, Lowest price target is $3, average price target is $6.67.
Most recent stock forecast was given by from MIZUHO on 18-Jun-2026. First documented stock forecast 10-Oct-2023.
Currently out of the existing stock ratings of NMRA, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jul-2024
$4
$2.36 (143.90%)
$5
26 days ago
(18-Jun-2026)
0/6 (0%)
$2.49 (164.90%)
Buy Since 01-Oct-2024
$7
$5.36 (326.83%)
$18
28 days ago
(16-Jun-2026)
0/8 (0%)
$5.44 (348.72%)
Buy Since 22-Jul-2024
$5
$3.36 (204.88%)
$8
28 days ago
(16-Jun-2026)
0/8 (0%)
$3.44 (220.51%)
Buy Since 31-Mar-2026
$14
$12.36 (753.66%)
3 months 13 days ago
(31-Mar-2026)
0/2 (0%)
$12.05 (617.95%)
Hold Since 04-Mar-2025
$7
$5.36 (326.83%)
$4
7 months 13 days ago
(01-Dec-2025)
0/10 (0%)
$4.58 (189.26%)
What is NMRA (Neumora Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NMRA (Neumora Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NMRA (Neumora Therapeutics)?
Which analyst is the currently most bullish on NMRA (Neumora Therapeutics)?
Which analyst is the currently most reserved on NMRA (Neumora Therapeutics)?
